Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance.

@article{Futscher1996VerapamilST,
  title={Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance.},
  author={Bernard W. Futscher and N E Foley and Mary C Gleason-Guzman and Paul S. Meltzer and Dan M. Sullivan and William S Dalton},
  journal={International journal of cancer},
  year={1996},
  volume={66 4},
  pages={520-5}
}
Selection protocols were designed to determine whether non-cytotoxic chemomodifiers can influence the evolution of the drug-resistant phenotype. To this end, the human multiple myeloma cell line RPMI 8226 (8226/S) was selected with either doxorubicin, verapamil or doxorubicin plus verapamil. Using this approach low-level multi-drug-resistant (MDR) cell lines were obtained when 8226/S was selected with doxorubicin only or doxorubicin plus verapamil but not with verapamil only. The MDR phenotypes… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors.

Drug metabolism and disposition: the biological fate of chemicals • 2005
View 1 Excerpt

Similar Papers

Loading similar papers…